Skip to Content

Feature Reviews in Radiopharmaceutical Sciences: Highlights of Two-Decade Development

This special issue belongs to the section "Radiopharmaceutical Sciences".

Special Issue Information

Keywords

  • nuclear medicine
  • positron emission tomography
  • single photon emission tomography
  • endoradiotherapy
  • (radionuclide)theranostics
  • personalized medicine
  • radionuclides
  • radiopharmaceuticals
  • cancer
  • diabetes
  • fibrosis
  • inflammation
  • infection
  • neurology
  • heart disease
  • drug development
  • tracers for oncological, cardiological, and neurological Nuclear Medicine
  • tracers for infection and inflammation, theranostic tracers/radiopharmaceuticals
  • emerging theranostic radionuclides and their upscaling
  • PET/CT, PET/MRI, SPECT/CT, optical imaging including fluorescent dye conjugates for image guided surgery, Can we transfer the theranostic concept to the tumor microenvironment
  • radiohalogenation methods for fluorine, bromine, iodine, astatine
  • radiometalation methods
  • emerging complexing agents for radiometalation
  • emerging theranostic biological targets
  • imaging biomarkers for non-invasive imaging
  • providing the radioindicator concept for drug development
  • tracers for distinct diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Published Papers

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247